KALINTIS HEALTHCARE PVT LTD

Overview

KALINTIS HEALTHCARE PVT LTD is an active pharmaceutical ingredient (API) supplier with 12 active FDA Type II Drug Master Files, covering BENZTROPINE MESYLATE USP; CEVIMELINE HYDROCHLORIDE USP; DIPHENOXYLATE HYDROCHLORIDE; DIPHENOXYLATE HYDROCHLORIDE USP + ATROPINE SULPHATE USP MIXTURE; FUROSEMIDE USP; LORAZEPAM USP.

API / Drug Master Files

KALINTIS HEALTHCARE PVT LTD holds 12 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TRIMETHOBENZAMIDE HYDROCHLORIDEActive2026-03-28
• METHENAMINE HIPPURATE USPActive2025-12-06
• DIPHENOXYLATE HYDROCHLORIDEActive2025-09-30
• DIPHENOXYLATE HYDROCHLORIDE USP + ATROPINE SULPHATE USP MIXTUREActive2025-07-17
• METHIMAZOLE USPActive2024-12-02
• CEVIMELINE HYDROCHLORIDE USPActive2023-09-25
• OXAZEPAM USPActive2022-12-10
• TORSEMIDE USPActive2022-01-20
• LORAZEPAM USPActive2020-12-11
• MEXILETINE HYDROCHLORIDE USPActive2020-09-23
• BENZTROPINE MESYLATE USPActive2020-07-29
• FUROSEMIDE USPActive2018-08-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to KALINTIS HEALTHCARE PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.